# FDA Inspection 1102300 - Resilience Boston Inc. - August 21, 2019

Source: https://www.keypedia.com/records/fda_inspections/resilience-boston-inc/a4070bd2-8f28-4031-9afa-4c8c2a326da5
Source feed: FDA_Inspections

> FDA Inspection 1102300 for Resilience Boston Inc. on August 21, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1102300
- Company Name: Resilience Boston Inc.
- Inspection Date: 2019-08-21
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1028333 - 2017-09-14](https://www.keypedia.com/records/fda_inspections/resilience-boston-inc/29624ba4-250c-40fc-b646-b4ec651e3851)
- [FDA Inspection 1021959 - 2017-08-11](https://www.keypedia.com/records/fda_inspections/resilience-boston-inc/7149db55-a0d6-45a9-b927-d89a977a24d4)
- [FDA Inspection 897817 - 2014-09-25](https://www.keypedia.com/records/fda_inspections/resilience-boston-inc/1b6674da-91e5-456e-afba-1090c029c3cb)
- [FDA Inspection 625796 - 2009-11-13](https://www.keypedia.com/records/fda_inspections/resilience-boston-inc/a6cce063-c616-4d41-a6a9-0b9d51829204)
- [FDA Inspection 595314 - 2009-05-28](https://www.keypedia.com/records/fda_inspections/resilience-boston-inc/7b596ad0-4510-42d1-905d-68d66c75d54a)

Company: https://www.keypedia.com/companies/resilience-boston-inc/f20c4d81-432a-4fb6-9e24-c920285d7419

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c